Semaglutide vs HRT for menopause weight gain
Weight gain in menopause has two drivers — hormone shift and insulin resistance. Sometimes both need addressing.
What the evidence shows
Clinical trials and real-world Kindr patient data align: GLP-1 and HRT are additive, not conflicting.
How Kindr coordinates care
Same clinical team manages both medications, so nothing falls through the cracks.
Getting started
A single video visit reviews goals, labs, and medication history.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.